FindTrial
Sign In

To study the Efficacy of Gandhakadi Tail and Rasnadi Guggulu in the treatment of Pootikarana w.s.r to CSOM

A Clinical study to evaluate the effect of Gandhakadi tail and Rasanadi Guggulu in the management of Pootikarana w.s.r to CSOM

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/033928
Enrollment
30
Registered
2021-06-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H663- Other chronic suppurative otitis media

Interventions

Intervention1: Gandhakadi tail and Rasnadi guggulu: Gandhakadi tail 2ml each ear Rasnadi guggulu 500mg tid for 2 weeks Control Intervention1: Gandhakadi tali: 2ml each ear for 2 weeks Control Interven

Sponsors

Principal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with signs and symptoms of Pootikarana Age above 12 years irrespective of sex, caste and religion etc.

Exclusion criteria

Exclusion criteria: Congenital deformity Malignancy presenting as pootikarana Established diabetes mellitus,hypertention Diseases other than ear pathology like: CSF ottorrhoea Parotid abscess rupturing in EAC TMJ abscess rupture in EAC Pregnant patients Patients not willing to be registered for the trial.

Design outcomes

Primary

MeasureTime frame
Relief in symptoms in patients of csomTimepoint: 2 weeks—

Secondary

MeasureTime frame
To study efficacy of Gandhakadi tail and Rasnadi guggulu in improvement in hearing loss, middle ear mucosa and perforation in CSOM patientsTimepoint: 2 weeks—

Countries

India

Contacts

Public ContactDr Shilpa chaudhary

RGGPG Ayurvedic College Paprola

Bhardwajvijayant@gmail.com9418017568

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026